2) is an exceedingly potent and rare marine-derived antitumor compound isolated from the Caribbean tunicate Ecteinascidia turbinata, 3) and is currently being studied in phase II/III clinical trials for ovarian, breast, endometrial, prostate, and pediatric cancers.
and this strategy has subsequently enabled its large-scale preparation. 7, 8) In addition, two independent groups, Fukuyama et al. 9) and Zhu et al., 10) were able to design synthetic routes to 1a. Ecteinascidin 743 is the first of a new class of DNA binding agents having a complex transcriptiontargeted mechanism of action. Although the detailed molecular mechanism of action remains unclear, 1a was reported to induce the DNA-sequence-selective alkylation of guanine N2 in a minor groove of duplex DNA. 11) Interestingly, the C-subunit, which is perpendicular to the combined AB-subunit, is responsible for the propeller-like character of pentacyclic natural products, such as saframycins and renieramycins, 12) both of which are fairly flat molecules. It was postulated that this bending structure of 1a disrupts DNA-protein binding and may be responsible for the enhanced biological activities of ecteinascidins. 13, 14) We succeeded in isolating the stable ecteinascidin 770 (1b) along with ecteinascidin 786 (1c) from the Thai tunicate, Ecteinascidia thurstoni, which was pretreated with potassium cyanide in buffer solution.
1) The availability of 1b enabled us to prepare ecteinascidin analogs having increased antitumor activity and broadened spectrum. In this work, we focused on the conversion of 1b into corresponding aromatic ester derivatives 3-19 along with diacetates 2a-c.
Results and Discussion
According to the procedure for the acetylation of 1a to the corresponding acetate in a published patent, 15) we treated 1b with acetic anhydride in pyridine to give 2b in 82% yield ( Fig. 1) . Oxidation of 1b with m-chloroperbenzoic acid (m-CPBA) in dichloromethane gave ecteinascidin 786 (1c) in 92% yield. 16 ) Treatment of 1c with acetic anhydride in pyridine afforded 2c in 78% yield. Compound 2a was obtained by reacting 2b with AgNO 3 in 41% yield, along with the recovery of 2b in 46% yield. In the primary screening for in vitro cytotoxicity, three human solid tumor cell lines (HCT116 colon carcinoma, QG56 lung carcinoma, and DU145 prostate carcinoma) were used. As shown in Table 1 , diacetyl derivatives 2a-c possessed low cytotoxicity relative to 1b. Oxidation of the sulfide group of ecteinascidins resulted in dramatically diminished cytotoxicity.
Next, we examined the transformation of 1b into the corresponding aromatic ester derivatives. In contrast with the acetylation of 1b as above, treatment of 1b with benzoyl chloride and a catalytic amount of 4-dimethylaminopyridine (DMAP) in pyridine afforded mainly monoacylated compound 3 in 88% yield (Fig. 2 ). In addition, fourteen monoacyl derivatives (4-17) of 1b, including substituted benzoyl, pyridinoyl, naphthoyl, and quinolinoyl, were obtained in a similar manner in 66-99% yields. No isoquinolinoyl derivatives 18 and 19 were obtained from 1b with the corresponding acid chloride in the same manner; however, these com-pounds were obtained by treating 1b with corresponding mixed anhydrides 20a and 20b, in 65% and 85% yields, respectively. 17) All compounds were characterized by IR, mass, and NMR measurements.
The assignment of acyl substituents at C-6Ј in the C-subunit of monoacyl derivatives 3-19 was made by NMR analysis. Prior to the determination of aromatic ester orientation for 1b, all proton and carbon signals of 2b were assigned using H-H, H-C COSY, and a series of 1 H detected two-dimensional heteronuclear multiple-bond correlation (HMBC) experiments, as shown in Table 2 . The signal of aromatic C-6Ј carbon was shifted upfield, whereas the signals of C-5Ј, C-7Ј, and C-9Ј carbons were shifted downfield compared with those of 1b. In the A-subunit, the signals of C-15 and C-19 carbons were shifted downfield compared with that of 1b. The 13 C-NMR spectral data of the mononitrobenzoyl derivative 4 and 1b revealed three major differences. The signals of C-5Ј, C-7Ј and C-9Ј quaternary carbons of 4 were shifted downfield to d 122. 3 . Together, these data confirmed that the free OH group at C-18 in 4 might be oriented. The cytotoxicites of 4-6 that possessed a nitro group on the benzene ring, and those of 10 and 11 that possessed a methoxy group on the benzene ring, were similar to that of 1b against all the cell lines investigated. On the other hand, 7-9 and 14-15, which possessed, respectively, a bromo group on the benzene ring and a naphthoyl group, showed significantly decreased cytotoxicity. This reduction of cytotoxicity might be due to steric hindrance. It is noteworthy that nitrogen-containing heterocycles 12, 13, 16-19 had high cytotoxicity. Thus, we were interested in the preparation of other esters such as 21 (Fig. 3) . However, numerous efforts aimed at transforming of 1b into 21 were unsuccessful, and only starting material 1b was recovered. Finally, we prepared N-indole-3-carbonyl derivative 22. Coupling of 1b with indole-3-carboxylic acid in the presence of N,NЈ-dicyclohexylcarbodiimide (DCC) provided amide 22 in 65% yield. The major differences in the 13 C-NMR spectral data between 22 and 1b were the downfield shifts of the signals of carbons adjacent to the nitrogen atom in the C-subunit, namely, from d 64.9 ppm (C-1Ј) and d 42.3 ppm (C-12Ј) for 1b to d 70.2 ppm and d 46.6 ppm for 22, respectively. The characteristic upfield shifts of the A-subunit protons of 22 at d 5.41 ppm (15-H), d 3.37 ppm (17-OCH 3 ), and d 1.14 ppm (16-CH 3 ) confirmed that these protons lie in the ring current of the indole ring (see Table 2 ). This compound showed very high cytotoxicity to the three human tumor cell lines in vitro. Further evaluation of 22 and synthetic efforts aimed at other analogs related to 22 are under way.
18)

Experimental
Optical rotations were recorded on a Horiba-SEPA polarimeter. IR spectra were measured on a Shimadzu FT-IR 8200PC spectrophotometer.
1 H-, 13 C-NMR, COSY, HMBC, and NOESY spectra were recorded on a JEOL JNM-LA-500 FT-NMR spectrometer at 500 MHz for 1 H and 125 MHz for 13 C, and on a JEOL JNM-EX 270 spectrometer at 270 MHz for 1 H and 67.5 MHz for 13 C, using TMS as internal standard. The chemical shifts are given in d (ppm) and coupling constants, in Hz. Mass spectra were recorded on a JMS 700 instrument with a direct inlet system operating at 70 eV. All reactions were conducted under argon atmosphere. Dry solvents and reagents were obtained using standard preparations. Removal of solvent was accomplished with a rotary evaporator and finally under high vacuum. Column chromatography was performed with silica gel 60 (Merck).
Extraction and Isolation Ecteinascidia thurstoni was collected by scuba divers at the east coast of Phuket Island at a depth of 1-5 m in four separate sampling periods from October 2002 to June 2003, and the combined animals were frozen until used. The frozen-animals (totally 136.4 kg, wet weight) were homogenized and phosphate buffer solution was added until the pH reached 7. Then, 10% potassium cyanide solution was added very slowly to the suspension, and the mixture was stirred for 5 h and extracted with methanol. After performing usual extraction and purification 1.426 g and 435.5 mg of ecteinascidins 770 (1b) and 786 (1c) were obtained, respectively.
Conversion of 1b into 1c Ecteinascidin 770 (1b, 30.8 mg, 0.04 mmol) was dissolved in dichloromethane (3.0 ml), and m-CPBA (80%, 9.5 mg, 0.044 mmol, 1.1 eq) was added slowly to the solution. After stirring at 0°C for 30 min, the mixture was diluted with water (30 ml) and extracted with dichloromethane (20 mlϫ3). The combined extracts were washed successively with 5% NaHCO 3 solution and water, dried, and concentrated in vacuo to give a residue. Chromatography on a silica gel column with hexane-ethyl acetate (1 : 3) as the eluent solvent gave 1c (29.0 mg, 92%) as a solid, which was identical in all respects with the authentic sample.
1)
Diacetylecteinascidin 770 (2b) Acetic anhydride (4.7 ml, 0.05 mmol) was added to a stirred solution of 1b (7.7 mg, 0.01 mmol) and DMAP (0.6 mg, 0.005 mmol) in pyridine (1.0 ml) at 0°C, and the resulting solution was stirred for 4 h at 25°C. After the solvent was removed in vacuo, the residue was diluted with water (10 ml) and extracted with chloroform (20 mlϫ3). The combined extracts were washed with brine (20 ml), dried, and concentrated in vacuo to give a solid (10.7 mg). Chromatography on a silica gel column with hexane-ethyl acetate (4 : 1) as eluent gave 2b (7.3 mg, 82%) as a pale yellow solid. 1 Diacetylecteinascidin 743 (2a) Compound 2b (9.0 mg, 0.011 mmol) was dissolved in a mixture of acetonitrile and water [3 : 2 (v/v), 3.5 ml], and silver nitrate (42.7 mg, 0.25 mmol, 23.8 eq) was added.. The suspension was stirred at 40°C for 19 h. The reaction mixture was filtered and the precipitate was washed carefully with chloroform (30 ml). The combined filtrates were concentrated in vacuo to give a residue. This residue was diluted with water (10 ml) and extracted with chloroform (30 mlϫ3). The combined extracts were washed with brine (30 ml), dried, and concentrated in vacuo to give a residue (11.6 mg). The residue was purified by silica gel column chromatography with hexane-ethyl acetate (3 : 
General Procedure for the Preparation of Compounds 3-17
Compound 1b (7.7 mg, 0.01 mmol) and DMAP (0.6 mg) were dissolved in pyridine (1 ml), and equimolar quantity of various acid chlorides (0.01 mmol) was added to this mixture at 0°C. The reaction mixture was stirred at 25°C for 4-12 h. After the solvent was removed in vacuo, the residue was diluted with water (10 ml) and extracted with chloroform (20 mlϫ3). The combined extracts were washed with brine (20 ml), dried, and concentrated in vacuo to give a solid. This residue was purified by silica gel column chromatography using appropriate eluent to give the purified product.
Ecteinascidin C-1Ј), 61.1 (C-1), 60.3 (17-OCH 3 (3H, s, 7Ј-OCH 3 ), 3.53 (1H, d, Jϭ5.0 Hz, 3-H), 3.43 (1H, br t,  13-H), 3.14 (1H, m, 3Ј-H), 2.96 (2H, d, Jϭ6.1 Hz, 14-H 2 ), 2.82 (1H, m, 3Ј-H), 2.68 (1H, m, 4Ј-H), 2.52 (1H, m, 4Ј-H), 2.33 (1H, br, 12Ј-H), 2.33 (3H,  s, 16-CH 3 ), 2.28 (3H, s, OCOCH 3 ), 2.23 (3H, s, NCH 3 ), 2.21 (1H, br, 12-H C-1), 60.3 (17-OCH 3 ), 60.2 (C-22), 59.7 (C-21), 59.6 (C-3 
